What To Expect From Herbalife’s (HLF) Q2 Earnings
Herbalife (NYSE: HLF) is set to report Q2 earnings Wednesday after market hours. Last quarter, it posted revenue of $1.32B, up 7.8% YoY, beating revenue estimates, with EPS beating but EBITDA missing. Q2 revenue is expected to rise 3.9% YoY. Analysts largely reconfirm estimates; average price target is $18.33 vs $12.73.
How this was made
The 30-second read
Why it matters
Traders can use the provided consensus revenue growth and the company’s recent pattern of revenue-estimate misses to position for earnings volatility, but there is no new fundamental disclosure beyond the scheduled event.
Market read
Earnings preview provides consensus revenue growth (3.9% YoY) and recent estimate behavior, implying a setup for after-hours volatility.
What to watch
The preview highlights revenue and EBITDA/EPS estimate dynamics, but does not discuss margins, guidance, or cash flow, which often drive the post-earnings move.
Background
The article frames Herbalife’s upcoming Q2 earnings, referencing last quarter’s revenue beat and EPS beat but EBITDA miss, plus recent estimate reconfirmations.
Ticker impact
Herbalife (HLF) is set to report Q2 results Wednesday after market hours, with consensus revenue growth at 3.9% YoY.
Near-term volatility likely around the after-hours earnings release, but direction is uncertain from the article alone.
The article provides expectations (revenue growth 3.9% YoY) and notes prior revenue misses, but it does not disclose any new company-specific development beyond the scheduled earnings timing.
Market effects
Peers’ mixed Q2 results (Medifast down, Vita Coco up then down) suggest consumer staples demand signals may be uneven, affecting read-across sentiment.
No specific regional impact described.
No global macro or cross-border catalyst described.
Counterpoint
If HLF’s revenue growth re-accelerates toward the 3.9% YoY expectation, the stock could outperform despite the company’s recent revenue-miss history.
Key entities
- companyHerbalife
Subject of the preview, scheduled to report Q2 earnings after market hours Wednesday.
- companyMedifast
Peer cited for Q2 results as a potential read-across (revenues down 27.6% YoY, beat by 5.1%).
- companyVita Coco
Peer cited for Q2 results as a potential read-across (revenues up 28.1% YoY, topped estimates, shares down 11.4%).
